Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Persistent prurigo nodularis responsive to initiation of combination therapy with raltegravir.

Unemori P, Leslie KS, Maurer T.

Arch Dermatol. 2010 Jun;146(6):682-3. doi: 10.1001/archdermatol.2010.128. No abstract available.

2.

Persistent prurigo nodularis in HIV-infected patient responsive to antiretroviral therapy with raltegravir.

Motegi S, Kato M, Uchiyama A, Yamada K, Shimizu A, Amano H, Ishikawa O.

J Dermatol. 2014 Mar;41(3):272-3. doi: 10.1111/1346-8138.12408. Epub 2014 Jan 31. No abstract available.

PMID:
24479440
3.

Combination therapy of fexofenadine and montelukast is effective in prurigo nodularis and pemphigoid nodularis.

Shintani T, Ohata C, Koga H, Ohyama B, Hamada T, Nakama T, Furumura M, Tsuruta D, Ishii N, Hashimoto T.

Dermatol Ther. 2014 May-Jun;27(3):135-9. doi: 10.1111/dth.12094. Epub 2013 Sep 17.

PMID:
24102897
4.

Prurigo nodularis and Hashimoto thyroiditis.

Rishi R, Ringwala S, Tracy J, Fatteh S.

Ann Allergy Asthma Immunol. 2014 Dec;113(6):673-4. doi: 10.1016/j.anai.2014.09.010. Epub 2014 Oct 16. No abstract available.

PMID:
25446192
5.

Antipruritic effect of cyclosporine microemulsion in prurigo nodularis: results of a case series.

Siepmann D, Luger TA, Ständer S.

J Dtsch Dermatol Ges. 2008 Nov;6(11):941-6. doi: 10.1111/j.1610-0387.2008.06745.x. Epub 2008 Apr 28. English, German.

PMID:
18445069
6.

Treatment of prurigo nodularis with topical capsaicin.

Ständer S, Luger T, Metze D.

J Am Acad Dermatol. 2001 Mar;44(3):471-8.

PMID:
11209117
7.

Prurigo nodularis of Hyde treated with low-dose thalidomide.

Orlando A, Renna S, Cottone M.

Eur Rev Med Pharmacol Sci. 2009 Mar-Apr;13(2):141-5.

PMID:
19499850
8.
9.

Bullous pemphigoid and prurigo nodularis.

Roenigk RK, Dahl MV.

J Am Acad Dermatol. 1986 May;14(5 Pt 2):944-7.

PMID:
3519701
10.

Lack of a significant drug interaction between raltegravir and tenofovir.

Wenning LA, Friedman EJ, Kost JT, Breidinger SA, Stek JE, Lasseter KC, Gottesdiener KM, Chen J, Teppler H, Wagner JA, Stone JA, Iwamoto M.

Antimicrob Agents Chemother. 2008 Sep;52(9):3253-8. doi: 10.1128/AAC.00005-08. Epub 2008 Jul 14.

11.

Pruritic reticular eruption on the chest of a 24-year-old woman--quiz case. Diagnosis: Prurigo pigmentosa (PP).

Marín PR, Ochoa RA, Cudós ES, Muruzábal UF, Jiménez MC, Díaz de Arcaya CV.

Arch Dermatol. 2010 Jan;146(1):81-6. doi: 10.1001/archdermatol.2009.334-a. No abstract available.

PMID:
20083701
12.

Successful treatment of chronic intractable itching using oral pregabalin in a patient with diabetes and systemic prurigo nodularis: a case report of an iliopsoas muscle abscess.

Imai K, Kishimoto M, Tsujimoto T, Yamamoto-Honda R, Ihana N, Ono K, Hachiya R, Inoue K, Goto M, Goto A, Noto H, Kajio H, Noda M.

Intern Med. 2013;52(23):2629-33.

13.

Short-course raltegravir intensification does not increase 2 long terminal repeat episomal HIV-1 DNA in patients on effective antiretroviral therapy.

Besson GJ, McMahon D, Maldarelli F, Mellors JW.

Clin Infect Dis. 2012 Feb 1;54(3):451-3. doi: 10.1093/cid/cir721. Epub 2011 Oct 19. No abstract available.

14.

Plasma and intracellular pharmacokinetics of darunavir/ritonavir once daily and raltegravir once and twice daily in HIV-infected individuals.

Jackson A, Watson V, Back D, Khoo S, Liptrott N, Egan D, Gedela K, Higgs C, Abbas R, Gazzard B, Boffito M.

J Acquir Immune Defic Syndr. 2011 Dec 15;58(5):450-7. doi: 10.1097/QAI.0b013e3182364c67.

15.

Prurigo pigmentosa.

Shannon JF, Weedon D, Sharkey MP.

Australas J Dermatol. 2006 Nov;47(4):289-90.

PMID:
17034475
16.

Sustained antiretroviral effect of raltegravir after 96 weeks of combination therapy in treatment-naive patients with HIV-1 infection.

Markowitz M, Nguyen BY, Gotuzzo E, Mendo F, Ratanasuwan W, Kovacs C, Prada G, Morales-Ramirez JO, Crumpacker CS, Isaacs RD, Campbell H, Strohmaier KM, Wan H, Danovich RM, Teppler H; Protocol 004 Part II Study Team.

J Acquir Immune Defic Syndr. 2009 Nov 1;52(3):350-6. doi: 10.1097/QAI.0b013e3181b064b0.

PMID:
19648823
17.

[Can antiretroviral treatment eradicate Prurigo nodularis in HIV infected patients?].

Ouattara I, Eholié SP, Aoussi E, Bissagnéne E, Raffi F.

Med Mal Infect. 2009 Jun;39(6):415-6. doi: 10.1016/j.medmal.2009.01.002. Epub 2009 May 6. French. No abstract available.

PMID:
19423251
18.

Patch testing in prurigo nodularis.

Zelickson BD, McEvoy MT, Fransway AF.

Contact Dermatitis. 1989 May;20(5):321-5.

PMID:
2766699
19.

Predictive values of prurigo nodularis and herpes zoster for HIV infection and immunosuppression requiring HAART in French Guiana.

Magand F, Nacher M, Cazorla C, Cambazard F, Marie DS, Couppié P.

Trans R Soc Trop Med Hyg. 2011 Jul;105(7):401-4. doi: 10.1016/j.trstmh.2011.04.001. Epub 2011 May 28.

PMID:
21621233
20.

Oral tacrolimus treatment of pruritus in prurigo nodularis.

Halvorsen JA, Aasebø W.

Acta Derm Venereol. 2015 Sep;95(7):866-7. doi: 10.2340/00015555-2107. No abstract available.

Items per page

Supplemental Content

Write to the Help Desk